Stem cell transplants for patients with relapsed/refractory leukaemia

Keyphrases

• Elderly Patients 100%
• Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 100%
• Transplantation 100%
• Stem Cell Transplantation 100%
• Relapsed or Refractory Acute Myeloid Leukemia 100%
• Relapsed or Refractory 100%
• Leukemia 66%
• Well-defined 33%
• Comorbidity 33%
• High Risk 33%
• Chemotherapy 33%
• Relapsed Disease 33%
• Donor Lymphocytes 33%
• Reduced-intensity Conditioning 33%
• Targeted Therapy 33%
• Advanced Disease 33%
• Poor Prognosis 33%
• Refractory Disease 33%
• Transfusion 33%
• Acute Myeloid Leukemia 33%
• Myelodysplastic Syndrome 33%
• First Remission 33%
• Radioimmunotherapy 33%
• Alloimmunization 33%
• Transplantation Conditioning 33%
• Cord Blood Transplantation 33%
• Immune Repertoire 33%
• Leukemia Therapy 33%
• Lymphoid Malignancies 33%
• Molecular Surveillance 33%
• Nonmyeloablative 33%
• Alloimmune 33%
• Primary Refractory 33%
• Antibody-based Immunotherapy 33%
• Conditioning Treatment 33%
• Maternal Donor 33%
• Fragile Patients 33%
• Reaction Intensity 33%

Medicine and Dentistry

• Stem Cell Transplant 100%
• Leukemia 100%
• Allogeneic Stem Cell Transplantation 60%
• Elderly Patient 40%
• Immunotherapy 40%
• Diseases 40%
• Cord Blood 20%
• Reduced Intensity Conditioning 20%
• Targeted Therapy 20%
• Myelodysplastic Syndrome 20%
• Acute Myeloid Leukemia 20%
• Transplantation Conditioning 20%
• Alloimmunity 20%
• Comorbidity 20%
• Lymphocyte 20%

Immunology and Microbiology

• Stem Cell Transplant 100%
• Allogeneic Stem Cell Transplantation 100%
• Conditioning 66%
• Immunotherapy 66%
• Alloimmunity 33%
• Immune Repertoire 33%
• Myeloid 33%
• Lymphocyte 33%
• Comorbidity 33%